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ABSTRACT  
Punicic acid (c9t11c13-CLNA) is a conjugated linolenic fatty acid found at 72% concentration in 
pomegranate seed oil. While research has elucidated the positive health benefits of punicic 
acid’s metabolite, c9t11-CLA, little is known about the physiological effects of punicic acid (PA). 
This senior honors research thesis aims to elucidate how punicic acid alters fat and energy 
metabolism in a mouse model.  Male C57Bl6 mice were fed diets of 0% PA, 1% PA, or 2% PA 
for 4 or 16 weeks. We measured the extent to which punicic acid affected weight gain, food 
intake, food efficiency, insulin sensitivity, and fatty acid composition in mice.  Diets containing 
increased levels of punicic acid resulted in a dose-responsive accumulation of conjugated 
linolenic acid in skeletal muscle, liver, and epididymal adipose tissues. In an effort to determine 
if punicic acid altered genes responsive to peroxisome proliferator-activated receptor-gamma 
(PPARγ), I investigated how punicic acid alters the expression of genes involved in lipid and 
energy metabolism. Levels of mRNA of AP2 (FABP4), UCP1, and PPARγ were not significantly 
altered in epididymal fat by dietary treatments during the 16-week feeding study, while 
expression of UCP2 was significantly increased in mice fed the 2% PA diet. It remains to be 
determined if punicic acid serves as a weak ligand for PPARγ. Understanding the mechanism of 
punicic acid and its effects on energy metabolism may ultimately improve recommendations for 
those battling obesity or the numerous diseases associated with it.  
 
INTRODUCTION 
     An epidemic of obesity is threatening to 
undermine the health of people living in 
industrialized societies. Excess 
accumulation of adipose tissue is a major 
risk factor for insulin resistance, 
hyperglycemia, abnormal blood lipid 
profiles, and hypertension. All of these 
conditions contribute to cardiovascular 
disease, the leading cause of death in the 
Western world (Lehrke & Lazar, 2005). 
Obvious choices for reducing obesity 
include decreasing food intake and 
increasing physical activity. Rational 
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intervention for obesity requires an 
understanding of external factors, such as 
diet, as well as internal factors, such as 
adipocyte genes, development, and 
function. The overall goal of this senior 
honors research thesis is to characterize the 
ability of a dietary bioactive lipid, punicic 
acid, to influence diet, weight, and lipid 
metabolism in mice. Understanding the 
mechanism of punicic acid and its effects on 
energy metabolism may ultimately improve 
recommendations for those battling obesity 
or the numerous diseases associated with 
it.  
     The term, conjugated fatty acid, is a 
generic name for positional and geometric 
isomers of polyunsaturated fatty acids with 
conjugated double bonds (Arao et al., 
2004). One such fatty acid with potentially 
beneficial biological effects is conjugated 
linoleic acid (c9t11-CLA), existing naturally 
in ruminant fats such as beef, lamb, and 
dairy products. The fatty acid c9t11-CLA 
has been found to have many favorable 
physiological benefits, such as anti-
atherosclerosis, anti-obesity, and anti-tumor 
effects, as well as a role in regulating lipid 
metabolism   (Belury, 2002).  Conjugated 
fatty acids also exist in some plant seed 
oils. One such fatty acid is punicic acid 
(c9t11c13-CLNA), a conjugated linolenic 
fatty acid found at 72% concentration in 
pomegranate seed oil (Arao et al., 2004). 
Interestingly, punicic acid (PA) is 
metabolized to c9t11-CLA via a saturase 
mechanism, as shown in Figure 1 (Tsuzuki 
et al., 2006). 
     Studies have shown c9t11-CLA’s ability 
to reduce adipose tissue in several animal 
models of obesity, as well as its ability to 
positively affect muscle mass (Steck et al., 
2007). Mice with cancer cachexia 
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(symptoms include weight loss, skeletal 
muscle wasting, and fatigue) were fed a diet 
supplemented with 0.5 % c9t11-CLA. Mice 
experienced reduced muscle wasting, 
indicating that c9t11-CNA has the ability to 
protect against muscle atrophy in mice 
(Graves, Hitt, Pariza, Cook, & McCarthy, 
2005). 
     The physiological effects and 
mechanisms of action of punicic acid have 
not been well characterized. This study 
illuminates the metabolic effects of punicic 
acid on body weight, food intake, insulin 
sensitivity, and adipocyte differentiation. 
Mice were fed diets of 0% PA, 1% PA, or 
2% PA for 4 or 16 weeks. In addition to in-
vivo measurements, analysis of gene 
expression was conducted to further 
understand punicic acid’s effect on lipid 
metabolism.  
 
MATERIALS AND METHODS 
Animals and Diets. Male C57Bl6 mice 
were purchased from Charles River 
Laboratories (Wilmington, MA) at 4 weeks 
of age. Mice were housed in the OSU 
vivarium 6 mice/cage, 1 cage/group (4-week 
study) and 4 mice/cage, 4 cages/group (16-
wekk study) at 22 +/-0.5 degrees Celsius on 
a 12 hour day/night cycle.  Upon arrival, 
mice were allowed free access to chow food 
and water for 5 days to allow for 
stabilization of stress and metabolism in the 
animals after delivery.  Mice were weighed 
and randomized into diet groups.  Semi-
purified high-fat diets were prepared and 
pelleted by Research Diets Incorporated as 
shown in Table 1.  In two separate studies, 
mice were fed experimental diets of punicic 
acid for 4 or 16 weeks. Body weights and 
food intake (fed minus remainder in cage) 
were measured three times weekly. 
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Insulin Tolerance Test (ITT). The ITT was 
conducted at day 23 in the 4-week study in 
order to measure insulin sensitivity. Mice 
were fasted overnight for 12 hours and then 
injected intraperitoneally with 2 U/kg body 
weight insulin (Humulin® R, Eli Lilly and Co., 
Indianapolis, IN).  Glucose was measured 
from tail vein blood using a One Touch 
Ultra® (LifeScan, Inc., Milpitas, CA) glucose 
meter immediately prior to insulin injection 
(time 0) and 15, 30, 45, 60, 90, and 120 
minutes following the injection.  Incremental 
area under the glucose curve (AUC) was 
calculated as the net area contained 
between individual baselines (set by the 
glucose value at time 0) and curves 
(Wolever, Jenkins, Jenkins, & Josse, 1991). 
 
Necropsy. Mice were euthanized by 
overdose of isofluorane and cardiac 
puncture for exsanguinations. Excision of 
tissues included adipose depots, quadriceps 
muscle, and liver.  Tissues were weighed 
and immediately frozen in liquid nitrogen for 
analysis of fatty acids and mRNA levels.  
The mass of each tissue was expressed as 
a percentage of body mass on the day of 
necropsy.   
 
Fatty Acid Analysis. For quantifying fatty 
acid composition of liver, muscle, and 
epididymal fat, lipids were extracted by the 
modification of Folch and lipid extracts 
separated into neutral and phospholipids 
using a silica column procedure. Fatty acid 
methyl esters were prepared by incubating 
the fractions with tetramethylguanidine at 
100oC and analyzed by gas 
chromatography using a 30m Omegawax 
320 capillary column. Helium flow rate was 
30 ml/min. Oven temperature was 
programmed to start at 175oC for 4 minutes 
then increase to 220oC at a rate of 3oC/min 
(Belury & Kempa-Steczko, 1997). 
 
Quantitative Real-time PCR. Expression of 
RNA levels was analyzed by quantitative 
real-time PCR (Prism 7300 Sequence 
Detection System; Applied Biosystems, 
Foster City, CA, USA). Epididymal adipose 
was collected at necropsy and frozen at       
-80°C. Total RNA from epididymal adipose 
tissue was isolated using an RNeasy Lipid 
Tissue kit (Qiagen, Valencia, CA, USA).  
Total RNA was reversed transcribed with 
random hexamers using MultiScribe reverse 
transcriptase (Applied Biosystems). After 
cDNA synthesis, real-time PCR analysis 
was performed using predesigned primers 
and probes supplied by Applied Biosystems 
(TaqMan Gene Expression Assays, Applied 
Biosystems). The four primers investigated 
were: PPARγ, AP2 (FABP4), UCP1, and 
UCP2. Target gene expression was 
expressed as 2-DDct using comparative CT 
method and normalized to the expression of 
18S ribosomal RNA and the 0% PA control 
group (Livak & Schmittgen, 2001). 
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 Statistical Analysis. All data are 
presented as mean + standard error (s.e.). 
Comparisons were analyzed using one way 
ANOVA (MINITAB). Differences were 
considered significant at p < 0.05. 
 
RESULTS 
Body Weight, Food Intake, and Food 
Efficiency. Mice were fed diets composed 
of 0% PA, 1% PA, or 2% PA for 4 weeks or 
16 weeks.  In each of the two studies, there 
was evidence for increased body weight 
(Figures 2 and 3) and food intake (Figure 4) 
in the mice fed the 2% PA diet as compared 
to the 0% and 1% PA diet groups.  Body 
weights for mice in the 2% PA feeding study 
during the 16-week study were significantly 
increased as compared to the 0% and 1% 
PA feeding groups. Additionally, food 
efficiency increased significantly in mice fed 
the 2% PA diet during the 16-week study 
(Figure 4). Quadriceps muscle mass 
decreased significantly in mice fed the 1% 
PA and 2% PA diets during the 4-week 
study. The liver and epididymal adipose 
tissue masses were not significantly 
different between feeding groups in the 4-
week study (Figure 5).  
 
Fatty Acid Composition. The decrease in 
quadriceps muscle mass was accompanied 
by a dose-responsive increase in the 
quantity of punicic acid (c9t11c13-CLNA) 
and its saturated metabolite, c9t11-CLA in 
mice fed the 1% PA and 2% PA diets. 
Tissues measured for fatty acid content 
were the quadriceps muscle and liver 
tissues of mice fed the 4-week PA diet 
(Table 2).  
     Likewise, in the 16-week feeding study, 
the epididymal adipose tissue increased in 
its fatty acid content of punicic acid 
(c9t11c13-CLNA) and c9t11-CLA in a dose-
responsive manner (Table 2). Therefore, 
punicic acid has the ability to accumulate in 
the skeletal muscle, liver, and epididymal fat 
of mice. 
 
Insulin Tolerance Test (ITT). In the ITT of 
the 4-week PA study, the blood glucose 
level decreased rapidly with insulin 
injections. The blood glucose levels after 
insulin injection differed significantly 
between the 2% PA and the 0% PA and 1% 
PA feeding groups (Figure 6). Beginning at 
15 minutes after insulin injection, the blood 
glucose level for the 2% PA feeding group 
(at 123.7 mg/dl) remained lower than the 
glucose levels for both the 0% PA and 1% 
PA feeding groups throughout the 120 
minute ITT. At 120 minutes after insulin 
injection, the glucose levels were as follows: 
0% feeding group (135.7 mg/dl), 1% PA 
feeding group (152.8 mg/dl), and 2% PA 
feeding group (91.7 mg/dl). These data 
indicate that the 0% PA and 1% PA feeding 
groups were more insulin resistant and the 
2% PA group was more insulin sensitive.   
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Expression of Genes Involved in 
Adipocyte Differentiation, Lipid 
Metabolism, and Energy Consumption. 
Quantitative Real-time PCR of epididymal 
adipose tissue from the 16-week PA feeding 
study was conducted using four genes: 
PPARγ, AP2, UCP1, and UCP2. PPARγ is a 
transcription factor in the PPAR family. It 
plays a crucial role in adipocyte 
differentiation (Sharma & Staels, 2007). 
PPARγ may up-regulate genes such as 
adipocyte protein-2 (AP2), otherwise known 
as fatty acid binding protein-4 (FABP4). AP2 
is a fatty acid binding protein which 
facilitates the transfer of lipophilic molecules 
from the outer cell membrane to the 
intracellular PPARγ receptor. AP2 regulates 
fatty acid uptake and intracellular transport 
and indicates the ability of a fatty acid to be 
incorporated into an adipocyte 
(Chmurzyńska, 2006). Lastly, UCP1 and 
UCP2 are uncoupling proteins. The former 
is found in the mitochondria of brown 
adipose tissue, the latter is expressed 
ubiquitously throughout the body, most 
significantly in skeletal muscle. Both are 
used to generate heat through the 
uncoupling of oxidative phosphorylation, 
thus enhancing energy dissipation (Konishi 
et al., 2008).  
     Results of RT-PCR analysis presented 
no significant differences in the expression 
of PPARγ, AP2, and UCP1 in epididymal fat 
between diet groups. In contrast, the 
expression of UCP2 was significantly 
increased in the epididymal fat tissue of the 
2% PA feeding group (Figure 7).    
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DISCUSSION 
     The in-vivo data from the 4-week and 16-
week feeding studies show that punicic acid 
exerts physiological effects on mice. Mice 
fed the greatest concentrations of punicic 
acid (2%) experienced increased total body 
weight gain and reduced muscle mass. 
Food intake also increased for the 2% PA 
feeding group of both studies. These results 
were not expected given the ability of 
punicic acid’s metabolite, c9t11-CLA, to 
reduce adipose tissue in previous mouse 
and human studies (Steck et al., 2007). The 
mice fed 2% PA exhibited significantly 
increased body weights and food efficiency 
in the 16-week feeding study. This indicates 
that the mice fed 2% PA required less food 
to gain weight when compared to the 0% 
PA or 1% PA feeding groups. These data 
highlight the importance of time (16 weeks 
versus 4 weeks) in punicic acid’s ability to 
potentiate changes in body weight and food 
efficiency.    
     Fatty acid content was altered by higher 
punicic acid concentrations. Diets 
containing increased levels of punicic acid 
resulted in a dose-responsive accumulation 
of conjugated linolenic acid in skeletal 
muscle, liver, and epididymal fat of mice. 
While punicic acid accumulated in these 
tissues, it did not cause weight loss. In the 
4-week study, quadriceps muscle mass 
decreased in the 1% PA and 2% PA feeding 
groups while liver and epididymal fat 
remained relatively constant between 
feeding groups. While tissue mass only 
decreased significantly for skeletal muscle, 
these data indicate a correlation between 
increased body weight and punicic acid 
accumulation in liver, skeletal muscle, and 
adipose tissue.  
     While punicic acid may not be an 
effective weight suppressant in mice, it is 
interesting to consider its potential insulin-
sensitizing effect. As displayed in Figure 6, 
the ITT data from the 4-week PA feeding 
study show the 2% PA fed mice as the most 
insulin sensitive group. This presents a 
conundrum, since significant weight gain (as 
seen in the 2% PA feeding group) has been 
shown to lead to greater insulin resistance 
(Ruan & Pownall, 2009).  In the 4-week 
study, the 2% PA feeding group showed 
increased insulin sensitivity in comparison 
to the 0% PA and 1% PA feeding groups. A 
future study designed to investigate the 
correlation between punicic acid, adipose 
tissue, and insulin sensitivity is warranted.  
     To help characterize the molecular 
mechanism of punicic acid, four genes 
involved in fat and energy metabolism were 
investigated at the RNA level. Because we 
observed an increase in body weight and 
insulin sensitivity in mice fed the highest 
dosage of punicic acid, we first investigated 
the transcription factor PPARγ. PPARγ is 
predominately expressed in an adipose-
selective manner in both rodents and 
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humans (Hauner, 2002). As a master 
regulator of fat cell formation, PPARγ has 
emerged as a key controller of lipid 
metabolism and the progression of obesity 
(Lehrke & Lazar, 2005). 
     In addition, PPARγ has been shown to 
increase insulin sensitivity by adipocyte 
differentiation (Lee, Olson, & Evans, 2003). 
That is to say, PPARγ increases insulin 
sensitivity by storing fat where it belongs — 
in adipose tissue — rather than in non-
adipose depots. PPARγ activation results in 
the up-regulation of genes involved in 
insulin sensitivity, which ultimately reduces 
the risk for cardiovascular disease.  
     As a member of the nuclear receptor 
family, PPARγ is modulated by direct 
binding of lipid metabolites. It has been 
reported that polyunsaturated fatty acids are 
weak ligands of PPARγ (Hauner, 2002). It 
remains to be determined if punicic acid is a 
ligand for PPARγ. Since the 2% PA feeding 
group increased in both body weight and 
insulin sensitivity, we were interested to see 
an increase in RNA levels of PPARγ in 
epididymal (white adipose) fat tissue. 
Interestingly, we saw no significant 
differences in PPARγ expression between 
diet groups. This indicates that perhaps the 
adipose cells were not differentiating and 
merely expanding in size.  
     To further study the effect of punicic acid 
on lipid metabolism, the RNA expression of 
AP2 was investigated. AP2 is a PPARγ 
responsive gene which regulates fatty acid 
uptake and intracellular transport 
(Chmurzyńska, 2006). Similar to PPARγ, it 
too showed no significant differences in 
RNA expression between diet groups. While 
this may lead one to believe that fatty acids 
were not taken up by adipocytes, it is 
important to note that AP2 is only one of 
several PPARγ responsive genes. To fully 
understand punicic acid’s influence on 
adipocyte differentiation, future studies 
should investigate the transcription of other 
PPARγ-responsive genes involved in 
glucose and lipid metabolism. These would 
include lipoprotein lipase, fatty acid 
transporter protein, fatty acyl-CoA synthase, 
malic enzyme, glucokinase, and GLUT4 
glucose transporter (Hauner, 2002). 
     Additionally, PPARγ serves as a receptor 
for thiazolidinediones (TZDs), a class of oral 
anti-diabetic drugs which work through 
insulin sensitization. TZDs are the most 
potent triggers for adipocyte differentiation. 
These drugs help improve metabolic control 
in type II diabetics, which ultimately 
decreases the risk for obesity and 
cardiovascular disease (Hauner, 2002). 
TZDs reduce insulin resistance in adipose, 
muscle, and liver tissue. Interestingly, there 
is evidence from animal studies and clinical 
trials that treatment with TZDs also results 
in moderate weight gain, which could be a 
consequence of increased fat cell mass 
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(Hauner, 2002). This phenomenon parallels 
with treatment of punicic acid in mice. Mice 
fed concentrations of 2% PA resulted in 
enhanced weight gain. As a potential weak 
ligand of PPARγ, punicic acid could exhibit 
a similar mode of action as that of TZDs. 
Further research must be done to clarify 
punicic acid’s binding affinity to PPARγ. 
     Punicic acid may also play a role in the 
metabolism of uncoupling protein-2 (UCP2). 
UCP2 is expressed ubiquitously throughout 
the body. It is expected to enhance energy 
dissipation in tissues such as white adipose 
(epididymal fat) (Kelly et al., 1998). The 
increase in body weight in the 2% PA fed 
mice could be attributed to the 
enhancement of energy dissipation 
mediated by UCP2 in mature adipocytes.    
     UCP2 maps to a region on distal mouse 
chromosome 7 that has been linked to the 
phenotypes of obesity and type II diabetes. 
Previous research reported increased UCP2 
expression in adipose tissue by high-fat diet 
feeding (Surwit et al., 1998). 
Correspondingly, mice in the 4-week and 
16-week punicic acid studies were fed a 
high-fat diet (24% by weight) of punicic acid.   
Together, these associations indicate that 
the consumption of a high fat diet in the 
form of punicic acid may selectively up-
regulate UCP2 expression in white adipose 
tissue. This is important because an 
increase in UCP2 may correspond to 
increased oxidative stress. UCP2 has been 
suggested to affect the production of 
reactive oxygen species, which can 
ultimately damage DNA, lipid membranes, 
and tissues (Schrauwen & Hesselink, 2002). 
Determining exactly how UCP2 is related to 
energy metabolism and obesity in rodents 
and humans requires future study.  
     The mechanism for punicic acid 
contributing to obesity remains to be 
determined. Findings from this senior 
honors research thesis indicate that punicic 
acid has the ability to modulate weight gain, 
food intake, food efficiency, and energy 
metabolism in mice. Additionally, punicic 
acid could be an effective insulin-sensitizing 
agent as a ligand of PPARγ. Lower doses of 
punicic acid (1%) did not show significant 
levels of weight gain in mice. The biphasic 
response of this study indicates that the 
dosage of punicic acid is important in 
potentiating changes in metabolism. Future 
studies should investigate punicic acid’s 
ability to alter lipid and energy metabolism 
by changes in gene expression and insulin 
sensitivity. 
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